Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2019-10-02 Capital/Financing Update
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Jeonjin BioPharm) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure, which details changes to the capital structure and conversion terms of financial instruments, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2019-10-02 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) between Jeonjin BioPharm and the Public Procurement Service. It details the contract value, duration, and nature of the supply. Since this is a specific corporate event announcement regarding a commercial contract that does not fit into the other specialized categories like M&A or share issues, it is classified as a general regulatory filing.
2019-09-27 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Jeonjin Bio Pharm Co., Ltd. for the period ending June 30, 2019. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by Jeonjin BioPharm. It details the contract value, counterparty, and duration. Since this is a specific corporate event disclosure that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2019-07-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds by Pine Value Asset Management in Jeonjin BioPharm. This type of filing is specifically for disclosing significant changes in share ownership (crossing thresholds), which corresponds to the 'Major Shareholding Notification' category.
2019-07-03 Korean
증권발행결과(자율공시)(제5회차)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from Jeonjin BioPharm. It details the completion of a private placement of convertible bonds (CB), including the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2019-07-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.